Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px download

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in France and Monaco or involving organisations from these countries.

Total search results: 886 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Nicox–Infopro Digital: investor conference, 201709 supply service Nicox presents at Actionaria 2017 in Paris 2017-11-23
Nicox–Cantor Fitzgerald: investor conference, 201709 supply service Nicox presents at Cantor Fitzegerald Global Healthcare Conference in NY 2017-09-25
DBV Technologies–Morgan Stanley: investor conference, 201709 supply service DBV presents at Morgan Stanley Global Healthcare Conference NY 2017-09-12
DBV Technologies–Citigroup: investor conference, 201709 supply service DBV pariticipates in Citi’s 12th Annual Biotech Conference in Boston 2017-09-07
Genoskin–Andrew Lloyd Associates: public relations, 201708 service existent by ALA 2017-08-29
Nicox–SEVERAL: investment, 201708 capital increase €26.25m 3.5m new shares €7.5/share to French + foreign biotech investors 2017-08-15
Ecopro Research–Eurofins: investment, 201708 acquistion of Ecopro Research KK by Eurofins 2017-08-10
Japan Analytical Chemistry Consultants–Eurofins: investment, 201708 acquistion of JACC by Eurofins 2017-08-10
Sebia–Québec (govt): investment, 201708 acquisition of significant minority stake by CDPQ from Astorg + Montagu 2017-08-10
DiscoverX–Eurofins: investment, 201707– acquisition by Eurofins ANNOUNCED 2017-07-31
GenSight Biologics–RooneyPartners: public relations, 201707 service existent media relations by RooneyPartners 2017-07-28
GenSight Biologics–Trout Group: public relations, 201707 service existent investor relations by Trout Group 2017-07-28
Evosciences–Danaher: mass spectrometer, 201707– distribution of Sciex MS systems with flexible finacing packages via Evosciences in Europe 2017-07-27
Genkyotex–Alize RP: public relations, 201707 service existent media relations by Alize RP 2017-07-27
Genkyotex–LifeSci Advisors: public relations, 201707 service existent in US by LifeSci Advisors 2017-07-27
Genkyotex–NewCap: public relations, 201707 service existent IR by NewCap 2017-07-27
Tata Group–Eurofins: investment, 201707– acquisition of Advinus Therapeutics from Tata Group ANNOUNCED 2017-07-26
Sanofi–Ablynx: Nanobodies, 201707– collab + license ww excl €23m upfront + €2.4b milestones plus royalties dev + commerc for inflammatory diseases 2017-07-20
OSE Immunotherapeutics–France (govt): grant, 201707 Bpifrance grant €9.2m for developm of checkpoint inhibitor OSE-172 2017-07-19
Eurofins–SEVERAL: credit, 201707–202407 senior unsecured €650 Euro bond 7y at 2.125% due July 2024 2017-07-18
Bio-Access–Eurofins: investment, 201707– buy-out of minority shareholders for €100m ANNOUNCED 2017-07-17
Emergent BioSolutions–Sanofi: smallpox vaccine, 201707– acquisition of ACAM2000 business $97.5m upfront + $27.5m milestones by Emergent 2017-07-14
Nestlé–Enterome: diagnostics, 201707– collab establishm of 50/50 jv MDP to develop microbiome-based diagnostics except for immuno-oncology 2017-07-11
Protein Sciences–Sanofi: investment, 201707–201708 acquisition $650m upfront + $100m milestones by Sanofi 2017-07-11
Amatsigroup–Eurofins: investment, 201707– acquisition €130m plus some residual debt from Ekkio Capital 2017-07-10
Cellnovo–Consilium: public relations, 201707 service existentPR in UK by CSC 2017-07-07
Cellnovo–NewCap: public relations, 201707 service existent IR + PR in France by NewCap 2017-07-07
Cellnovo–SEVERAL: investment, 201707 capital increase €17.5m with 4.07m new shares at €4.3/share (discount of 27.2%) to institutional investors 2017-07-06
Ana Laboratories–Eurofins: investment, 201707 acquisition by Eurofins 2017-07-05
Servier–Mérieux: cell therapy, 201706– collab research viral vectorization techn for allogenic CAR-T cell therapy production w Transgene 2017-06-29
Servier–Plug and Play: digital health, 201706–202005 collab 3y incl WeHealth by Servier and Plug and Play Health & Wellness platform 2017-06-27
Genoma (IT)–Eurofins: investment, 201706 acquisition of Genoma Group Srl by Eurofins 2017-06-26
Cellectis–SEVERAL: investment, 201706–201707 Calyxt IPO $64.4m w 7m+1.05m common shares at $8/share Cellectis retains 79.9% shareholding 2017-06-23
ERICo (SI)–Eurofins: investment, 201706 acquisition of ERICo by Eurofins from Gorenje Group + two other shareholders 2017-06-23
GenSight Biologics–SEVERAL: investment, 201706 capital increase €22.5m €6/share with Europ + US institutional investors 2017-06-22
AlsaChim–Shimadzu: investment, 201706 acquisition €na of 100% of AlsaChim by Shimadzu Europe 2017-06-21
Novacyt–SEVERAL: investment, 201706 capital increase €3m net €2.8m w 3.53m new shares resulting in delution of 16% 2017-06-20
APG Bio (CN)–Genomic Vision: genomic technology, 201706– distribution of molecular combing technology in Greater China by APG Bio 2017-06-19
Onxeo–SEVERAL: investment, 201706 capital increase €15m with 3.5m new shares at €4.25/share to US + European institutional investors 2017-06-19
TxCell–Miltenyi Biotec: lentiviral vector, 201706– supply of lentiviral vector for TxCell’s CAR-Tregs targeting transplant rejection by Lentigen 2017-06-19
Medicxi Ventures–Alphabet: investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–EU (govt): investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–Novartis: investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–SEVERAL: investment, 201706 closing $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Alphora Research–Eurofins: investment, 201706 acquisition of Alphora by Eurofins 2017-06-13
Centogene–Careventures: investment, 201706 financing round Series A totalling €25m incl co-investor Careventures 2017-06-13
Centogene–Crédit Mutuel-CIC: investment, 201706 financing round Series A totalling €25m incl co-investor CIC Capital 2017-06-13
Centogene–DPE Deutsche Private Equity: investment, 201706 financing round Series A totalling €25m incl co-investor DPE 2017-06-13
Centogene–SEVERAL: investment, 201706 financing round Series A €25m led by TVM Capital + incl DPE + Careventures + CIC Capital 2017-06-13
Centogene–TVM: investment, 201706 financing round Series A totalling €25m incl lead investor TVM Capital Life Science 2017-06-13
Mérieux–Kepler Chevreux: investor conference, 201706 supply service Transgene SA presents at Kepler Biotech Days 2017 in Paris 2017-06-09
TxCell–Leucadia: investor conference, 201706 supply service TxCell at Jefferies Global Healthcare Conference 2017 in NY 2017-06-06
GATC Biotech–Eurofins: investment, 201706–201707 acquisition €na of GATC Biotech AG by Eurofins Scientific SE 2017-06-02
Innate Pharma–Novo Group: anti-C5aR antibody, 201706 acquisition ww rights IPH5401 €2.8m cash + €37.2m shares upfront + €370m milestones + royalties 2017-06-02
Innate Pharma–Novo Group: investment, 201706–201707 increase Novo Nordisk share from 10.3% to between 14.6% to 15.8% w €37.2m share issue 2017-06-02
Nab Labs (FI)–Eurofins: investment, 201706 acquisition of Nab Labs Group Oy by Eurofins 2017-06-01
AstraZeneca–Genomic Vision: genomic technology, 201705– collab using FiberVision DNA combing to develop WEE1 kinase inhibitors 2017-05-23
Genomic Vision–Milestones: public relations, 201705 service existent by Milestones 2017-05-23
Genomic Vision–NewCap: public relations, 201705 service existent investor relations by NewCap 2017-05-23
OSE Immunotherapeutics–Selexis: cell line development, 201705– commercial license for access to RCBs from SUREtechnology platform 2017-05-23
CureVac–Informa: investor conference, 201705 supply service CureVac presents at BioEquity Europe 2017 in Paris 2017-05-22
Macrophage Pharma–Informa: investor conference, 201705 supply service Macrophage Pharma presents at BioEquity Europe 2017 in Paris 2017-05-22
Medigene–Informa: investor conference, 201705 supply service Medigene presents at BioEquity Europe 2017 in Paris 2017-05-22
Probiodrug–Informa: investor conference, 201705 supply service Probiodrug presents at BioEquity Europe 2017 in Paris 2017-05-22
TxCell–Informa: investor conference, 201705 supply service TxCell presents at BioEquity Europe 2017 in Paris 2017-05-22
Boehringer–Anagenesis: drug discovery technology, 201705– excl license to P2MC technology for drug developm for chronic muscle diseases 2017-05-18
Vesalius Biocapital–SEVERAL: investment, 201705 first closing €65m of Vesalius Biocapital III fund 2017-05-15
Theradiag–SEVERAL: investment, 201705 capital increase €4m with 1.75m new shares at €2.3/share 2017-05-12
Sanofi–Exscientia: drug discovery, 201705– strategic research collab up to €250m using AI for bi-specific small-moleulces for metabolic disease 2017-05-09
MVZ für Laboratoriumsmedizin am Hygiene-Institut–Eurofins: investment, 201705– acquisition of Hygel by Eurofins ANNOUNCED 2017-05-04
Vivet Therapeutics–Columbus Venture Partners: investment, 201705 financing round Series A totalling €37.5m incl co-lead investor CVP 2017-05-04
Vivet Therapeutics–Huntsworth: public relations, 201705 service existent by Citigate Dewe Rogerson 2017-05-04
Vivet Therapeutics–Kurma: investment, 201705 financing round Series A totalling €37.5m incl co-investor Kurma Partners 2017-05-04
Vivet Therapeutics–Novartis: investment, 201705 financing round Series A totalling €37.5m incl co-lead investor Novartis Venture Fund 2017-05-04
Vivet Therapeutics–Odlander Fredrikson: investment, 201705 financing round Series A totalling €37.5m incl co-investor HealthCap 2017-05-04
Vivet Therapeutics–Roche: investment, 201705 financing round Series A totalling €37.5m incl co-investor Roche Venture Fund 2017-05-04
Vivet Therapeutics–SEVERAL: investment, 201705 financing round Series A €37.5m led by Novartis Venture Fund + Columbus Venture Partners 2017-05-04
Vivet Therapeutics–Ysios Capital: investment, 201705 financing round Series A totalling €37.5m incl co-investor Ysios Capital 2017-05-04
ImCheck Therapeutics–ATCG Partners: public relations, 201705 service existent by ATCG 2017-05-02
ImCheck Therapeutics–Boehringer: investment, 201705 financing round Series A totalling €20m incl co-lead investor BIVF 2017-05-02
ImCheck Therapeutics–Gimv: investment, 201705 financing round Series A totalling €20m incl co-investor Gimv 2017-05-02
ImCheck Therapeutics–IDI Group: investment, 201705 financing round Series A totalling €20m incl co-lead investor Idinvest 2017-05-02
ImCheck Therapeutics–Kurma: investment, 201705 financing round Series A totalling €20m incl co-lead investor Kurma Partners 2017-05-02
ImCheck Therapeutics–Life Sciences Partners: investment, 201705 financing round Series A totalling €20m incl co-investor LSP 2017-05-02
ImCheck Therapeutics–SEVERAL: investment, 201705 financing round Series A €20m from BIVF + Kurma Partners + Idinvest + Gimv + LSP 2017-05-02
TxCell–France (govt): T cell therapy, 201705– collab expansion €na r+d w Inserm Transfert + Univ Nantes for CAR-Tregs in transplantation + MS 2017-05-02
TxCell–NewCap: public relations, 201705 service existent Investor Relations by NewCap 2017-05-02
EMBL–Enamine: chemical compound library, 201704– collab library synthesis + medical chemistry + biological services for cancer drug research 2017-04-25
Pfizer–Domain Therapeutics: GPCR target discovery, 201704– collab using bioSensAll technology to profile + validate GPCR targets 2017-04-25
Advent France Biotechnology–Advent Venture Partners: fund management, 201704 service existent support by Advent Life Sciences 2017-04-20
Advent France Biotechnology–NewCap: public relations, 201704 service existent by NewCap 2017-04-20
Advent France Biotechnology–SEVERAL: investment, 201704 first closing €64.75m of Advent France Biotechology Seed-Fund I 2017-04-20
Biocartis–Sycomore Asset Management: investment, 201704 acquisition of shares resulting in 5.15% holding of voting rights in Biocartis 2017-04-19
Mérieux–Van Lanschot: investor conference, 201704 supply service Transgene SA presents at Kempen Life Sciences Conference 2017-04-19
EuroPharma–Universal Media Group: investment, 201704 acquisition of EuroPharma by UMG 2017-04-17
Erytech–SEVERAL: investment, 201704 private placement €70.5m with 3m new ordinary shares at €23.5/share 2017-04-12
Mérieux–Huntsworth: public relations, 201704 service existent for Transgene SA by Citigate Dewe Rogerson 2017-04-10
Nanobiotix–SEVERAL: investment, 201704 private placement €25.1m w 1.6m new shares €15.75/share to qualified US + EU investors 2017-04-06
Ahma–Eurofins: investment, 201704 acquisition of 2nd largest Finnish environmental testing lab Ahma Group by Eurofins 2017-04-04
Ramboll–Eurofins: investment, 201704 acquisition of analytical lab business of Ramboll in Finland by Eurofins 2017-04-03
1 2 3 4 5 6 7 8 9  next pagenext page



Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px download

» top

Advertisements

Picture Berlin Partner HealthCapital BIO-Europe 2017 Germany November 120x240px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px 22 Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Save USD100 120x180px Picture Berlin Partner HealthCapital BIO-Europe 2017 Germany November 120x240px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px 41 Picture EBD Group BioPharm America 2017 BPA Boston MA Save USD100 120x180px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px